Intrafollicular levels of matrix metalloproteinases-2 and -9 in patients with ovaries are not associated with pregnancy rate during IVF cycle

In Vivo

Volumn 23, Issue 1, 2009, Pages 89-92

  Baka, Stavroula ^a,b   Zourla, Konstantina ^a   Malamitsi Puchner, Ariadne ^a   Makrakis, Evangelos ^a   Kaparos, George ^a   Demeridou, Stella ^a   Moustakarias, Theodore ^a   Tzanakaki, Despoina ^a   Hassiakos, Dimitris ^a   Kouskouni, Evangelia ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Follicular Fluid; IVF; Matrix metalloproteinases; PCOS; Pregnancy

Indexed keywords

CHORIONIC GONADOTROPIN; GELATINASE A; GELATINASE B; GONADORELIN; ORAL CONTRACEPTIVE AGENT; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO TRANSFER; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; GELATINIZATION; HUMAN; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; PREGNANCY RATE;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR FLUID; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY RATE;

EID: 63049115248     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Russell DL, Salamunsen LA and Findlay JR: Immunization against the N-terminal peptide of the inhibin alpha Y3-subunit (Alpha N) disrupts tissue remodeling and the increase in matrix metalloproteinase-2 during ovulation. Endocrinology 136: 3657-3664, 1995.
2. Stamouli A, O'Sullivan MJ, Frankel S, Thomas EJ and Richardson MC: Suppression of matrix metalloproteinase production by hCG in cultures of human luteinized granulosa cells as a model for gonadotropin-induced luteal rescue. J Reprod Fertil 107: 235-239, 1996.
3. Wang H, Wen Y, Mooney S, Li H, Behr B and Polan ML: Matrix metalloproteinase and tissue inhibitor of matrix metallo-proteinase expression in human preimplantation embryos. Fertil Steril 80: 736-742, 2003.
4. Lee DM, Lee TK, Song HB and Kim CH: The expression of matrix metalloproteinase-9 in human follicular fluid is associated with in vitro fertilization pregnancy. BJOG: Int J Obstet Gyn 112: 946-951, 2005.
5. Lewandowski KC, Komorowski J, O'Callaghan CJ, Tan BK, Chen J, Prelevic GM and Randeva HS: Increased circulating levels of matrix metalloproteinase-2 and -9 in women with the polycystic ovary syndrome. J Clin Endocrinol Metab 91: 1173-1177, 2006.
6. Liu B, Cai LY, Lv HM, Xia L, Zhang YJ, Zhang HX and Guan YM: Raised serum levels of matrix metalloproteinase-9 in women with polycystic ovary syndrome and its association with insulin-like growth factor binding protein-1. Gynecol Endocrinol 24: 285-288, 2008.
7. Shalev E, Goldman S and Ben-Shlomo I: The balance between MMP-9 and MMP-2 and their tissue inhibitor (TIMP)-1 in luteinized granulosa cells: comparison between women with PCOS and normal ovulatory women. Mol Hum Reprod 7: 325-331, 2001.
8. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 1: 41-47, 2004.
9. Hulboy DL, Rudolph LA and Matrisian LM: Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod 3: 27-45, 1997.
10. Goldman S and Shalev E: MMPS and TIMPS in ovarian physiology and pathophysiology. Front Biosci 9: 2474-2483, 2004.
11. Riley SG, Gibson AH, Leask R, Mauchline DJ, Pedersen HG and Watson ED: Secretion of matrix metalloproteinases -2 and -9 and tissue inhibitor of metalloproteinases into follicular fluid during follicle development in equine ovaries. Reproduction 121: 553-560, 2001.
12. Imai K, Khandoker MA, Yonai M, Takahashi T, Sato T, Ito A, Hasegawa Y and Hashizume K: Matrix metalloproteinases -2 and -9 activities in bovine follicular fluid of different-sized follicles: relationship to intra-follicular inhibin and steroid concentrations. Domest Anim Endocrinol 24: 171-183, 2003.
13. Bagavandoss P: Differential distribution of gelatinases and tissue inhibitor of metalloproteinase-1 in the rat ovary. J Endocrinol 158: 221-228, 1998.
14. D'Ascenzo S, Giusti I, Millimaggi D, Marci R, Tatone C, Cardigno-Colonna R, Moscarini M, Pavan A, Dolo V and Caserta D: Intrafollicular expression of matrix metalloproteinases and their inhibitors in normally ovulating women compared with patients undergoing in vitro fertilization treatment. Eur J Endocrinol 151: 87-91, 2004.
15. Abdallah MA, Lin PC, Nakajima ST, Eblen AC, Kang S and Gercel-Taylor C: Comparisons of matrix metalloproteinase -1, -2, and -9 activity in periovulatory follicular fluid from natural and stimulated menstrual cycles. Fertil Steril 85: 800-801, 2006.
16. Lahav-Baratz S, Kraiem Z, Shiloh H, Koifman M, Ishai D and Dirnfeld M: Decreased expression of tissue inhibitor of matrix metalloproteinases in follicular fluid from women with polycystic ovaries compared with normally ovulating patients undergoing in vitro fertilization. Fertil Steril 79: 567-571, 2003.
17. Nikolettos N, Asimakopoulos B, Tentes L, Schopper B and Al-Hasani S: Matrix metalloproteinases 2 and 9 in follicular fluids of patients undergoing controlled ovarian stimulation for ICSI/ET. In Vivo 17: 201-204, 2003.
18. Ben-Schlomo I, Goldman S and Shalev E: Regulation of matrix metalloproteinase-9 (MMP-9), tissue inhibitor of MMP, and progesterone secretion in luteinized granulosa cells from normally ovulating women with polycystic ovary disease. Fertil Steril 79: 694-701, 2003.
19. Willis DS, Watson H, Mason HD, Galea R, Brincat M and Franks S: Premature response to luteinizing hormones of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab 83: 3984-3991, 1998.
20. Mason HD, Willis DS, Beard RW, Winston RM, Margara R and Franks S: Estradiol production by granulosa cells of normal and polycystic ovaries relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid. J Clin Endocrinol Metab 79: 1355-1360, 1994.
21. Shibahara H, Suzuki T, Ayustawati, Kikuchi K, Hirano Y and Suzuki M: Serum matrix metalloproteinase and tissue inhibitor of metalloproteinase concentrations in infertile women achieved pregnancy following IVF-ET. Am J Reprod Immunol 54: 186-192, 2005.